Kevin Bitterman, Director, 10% Owner at Editas Medicine, Inc. (EDIT), sold 130,000 shares at $15.87 ($2.1M) on 2016-12-06, disclosed to the SEC on 2016-12-07.
Open-market sale of $2.1M EDIT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.74 | 80,000 | $1.3M | 61.3% |
| 2 | $15.87 | 50,000 | $794K | 38.7% |
| Total | $15.79 avg | 130,000 | $2.1M | 100% |
| Filing → |
| IRON | SELL | 2026-09-03 | $4.4M | — | Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |